theheart.org: trusted cardiology news and opinions

ACC.13 Opening Showcase and Late-Breaking Clinical Trials
Session 300
Saturday, March 9, 8 – 10 am
South, Esplanade Ballroom

Cochairs:
Panagiotis E Vardas (Heraklion, Greece)
William A Zoghbi (Houston, TX)

Panelists:
Donna Arnett (Birmingham, AL)
Christie M Ballantyne (Houston, TX)

		Final Results of Randomized Trial of Left Atrial Appendage Closure vs Warfarin for Stroke/Thromboembolic Prevention in Patients with Nonvalvular Atrial Fibrillation (PREVAIL) 9:00 - 9:20 am David R Holmes (Mayo Clinic, Rochester, MN) Panel Discussion: 9:20 am - 9:30 am
		HPS2-THRIVE: Randomized Comparison of Extended-Release (ER) Niacin/Laropiprant 2 g Daily vs Placebo in 25 673 Patients at High Risk of Occlusive Vascular Events 9:30 - 9:50 am Jane Margaret Armitage (University of Oxford, UK) Panel Discussion: 9:50 am -10:00 am

Late-Breaking Clinical Trials II: Interventional
Session 301
Sunday, March 10, 8 – 9:30 am
South, Esplanade Ballroom

Cochairs:
David R Holmes (Rochester, MN)
Gregg W Stone (New York, NY)

Panelists:
Cindy L Grines (Detroit, MI)
Ajay J Kirtane (New York, NY)
Roxana Mehran (New York, NY)
Jeffrey J Popma (Newton, MA)

		Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome 8:00 - 8:10 am Anna Toso (Misericordia e Dolce Hospital, Prato, Italy) Panel Discussion: 8:10 - 8:18 am
		A Randomized Evaluation of the Sapien XT Transcatheter Valve System in Patients with Aortic Stenosis who are not Candidates for Surgery: PARTNER 2, Cohort B Outcomes 8:18 - 8:28 am Martin B Leon (Columbia University Medical Center, New York, NY) Panel Discussion: 8:28 - 8:36 am
		One-year Outcome of a Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORI Biolimus-Eluting vs XIENCE/PROMUS Everolimus-Eluting Stent Trial (NEXT) 8:36 - 8:46 am Masahiro Natsuaki (Kyoto University, Japan) Panel Discussion: 8:46 - 8:54 am
		Comparison Of DK Crush vs Culotte Stenting for Unprotected Distal Left Main Bifurcation Lesions: Results from the multicenter, randomized, prospective DKCRUSH-III study 8:54 - 9:04 am Shaoliang Chen (Nanjing First Hospital, Nanjing Medical University, People's Republic of China) Panel Discussion: 9:04 - 9:12 am
		The main results of the CHAMPION PHOENIX trial 9:12 - 9:22 am Deepak Bhatt (Harvard Medical School, Boston, MA) Panel Discussion: 9:22 - 9:30 am

Late-Breaking Clinical Trials III: Chronic CAD/Stable Ischemic Heart Disease and Acute Coronary Syndromes
Session 302
Sunday, March 10, 10:45 am – 12:15 pm
South, Esplanade Ballroom

Cochairs:
Keith AA Fox (Edinburgh, Scotland)
John Gordon Harold (Los Angeles, CA)

Panelists:
George D Dangas (New York, NY)
C Michael Gibson (Boston, MA)
Erik Magnus Ohman (Durham, NC)
Freek WA Verheugt (Amsterdam, the Netherlands)

		The STREAM Trial 10:45 - 10:55 am Frans JJ Van de Werf (University of Leuven, Belgium) Panel Discussion: 10:55 - 11:03 am
		Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER trial 11:03 -11:13 am Gilles Montalescot (Pitié-Salpêtrière University Hospital, Paris, France) Panel Discussion: 11:13 -11:21 am
		Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial 11:21 -11:31 am Jean-Claude Tardif (Montreal Heart Institute, QC) Panel Discussion: 11:31 -11:39 am
		Randomized Comparison of High-Dose Oral Vitamins vs Placebo in the Trial to Assess Chelation Therapy (TACT) 11:39 -11:49 am Gervasio A Lamas (Mount Sinai Medical Center, Miami Beach, FL) Panel Discussion: 11:49 - 11:57 am
		Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina (TERISA) randomized clinical trial 11:57 am -12:07 pm Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, MO) Panel Discussion: 12:07 -12:15 pm

Late-Breaking Clinical Trials IV: General Cardiology
Session 303
Monday, March 11, 8 – 9:30 am
South, Esplanade Ballroom

Cochairs:
Neal S Kleiman (Houston, TX)
Jeffrey B Rich (Norfolk, VA)

Panelists:
Christopher P Cannon (Boston, MA)
Michael J Mack (Plano, TX)
James B McClurken (Doylestown, PA)
Thomas P Wharton Jr (North Hampton, NH)

		Three-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement in High-Risk Patients with Severe Aortic Stenosis 8:00 am - 8:10 am Vinod Thourani (Emory University, Atlanta, GA) Panel Discussion: 8:10 - 8:18 am
		A Randomized Trial to Compare Percutaneous Coronary Intervention between Massachusetts Hospitals With Cardiac Surgery On Site and Community Hospitals Without Cardiac Surgery On Site 8:18 - 8:28 am Alice K Jacobs (Boston Medical Center, MA) Panel Discussion: 8:28 - 8:36 am
		The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) Study 8:36 am - 8:46 am Anno Diegeler (Herz-und Gefäßklinik Bad Neustadt, Germany) Panel Discussion: 8:46 - 8:54 am
		CORONARY: The Coronary Artery Bypass Grafting Surgery Off- or On-Pump Revascularization Study. Results at One Year 8:54 am - 9:04 am Andre Lamy (McMaster University, Hamilton, ON) Panel Discussion: 9:04 - 9:12 am
		PRAGUE-6 Trial: Off-Pump vs On-Pump Coronary Artery Bypass Graft Surgery in Patients With EuroSCORE =6 9:12 am - 9:22 am Jan Hlavicka (Charles University, Prague, Czech Republic) Panel Discussion: 9:22 - 9:30 am

Late-Breaking Clinical Trials V: Heart Failure
Session 304
Monday, March 11, 10:45 am – 12:15 pm
South, Esplanade Ballroom

Cochairs:
Mariell Jessup (Philadelphia, PA)
Guillermo Torre-Amione (Houston, TX)

Panelists:
Biykem Bozkurt (Houston, TX)
Dennis M McNamara (Pittsburgh, PA)
Christopher M O'Connor (Durham, NC)

		The St Vincent's Screening to Prevent Heart Failure Study: Impact of Natriuretic Peptide Guided Screening and Treatment on Long-Term Prevalence of Left Ventricular Dysfunction, Heart Failure, and Cardiovascular Events 10:45 -10:54 am Kenneth M McDonald (University College Dublin, Ireland) Panel Discussion: 10:54 -11:00 am
		Digoxin Reduces 30-Day All-Cause Hospital Admission in Ambulatory Older Patients With Chronic Heart Failure and Reduced Ejection Fraction 11:00 - 11:09 am Ali Ahmed (University of Alabama at Birmingham) Panel Discussion: 11:09 -11:15 am
		The ASTRONAUT Study: Aliskiren Trial on Acute Heart Failure Outcomes 11:15 -11:24 am Mihai Gheorghiade (Northwestern University Feinberg School of Medicine, Chicago, IL) Panel Discussion: 11:24 -11:30 am
		Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) Trial 11:30 -11:39 am Margaret Redfield (Mayo Clinic, Rochester, MN) Panel Discussion: 11:39 -11:45 am
		Single-bolus Tenecteplase Plus Heparin Compared With Heparin Alone for Normotensive Patients With Acute Pulmonary Embolism Who Have Evidence of Right Ventricular Dysfunction and Myocardial Injury: The Pulmonary Embolism Thrombolysis (PEITHO) Study 11:45 -11:54 am Stavros Konstantinides (University Medical Center, Mainz, Germany) Panel Discussion: 11:54 -12:00 pm